4.8 Article

Ni(II) activates the Nrf2 signaling pathway in human monocytic cells

Journal

BIOMATERIALS
Volume 27, Issue 31, Pages 5348-5356

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2006.06.007

Keywords

dental alloy; inflammation; monocyte; nickel; biocompatibility

Ask authors/readers for more resources

Nickel is a component of biomedical alloys that is released during corrosion and causes inflammation in tissues by as yet unknown mechanisms. Recent data show that Ni(II) at concentrations of 10-50 mu M amplifies lipopolysaccharide-triggered, NF kappa B-mediated cytokine secretion from monocytes. In the current study, we tested the hypothesis that Ni(II) amplifies cytokine secretion by activating the Nrf2 antioxidant pathway rather than by enhancing activity of the NF kappa B signaling pathway. Human THP1 monocytes were exposed to Ni(11) concentrations of 10-30 mu M for 6-72 h, then immunoblots of whole-cell lysates or cytosolic and nuclear proteins were used to detect changes in Nrf2 or NF kappa B signaling. Our results show that Ni(II) increased (by 1-2 fold) whole-cell Nrf2 levels and nuclear translocation of Nrf2, and amplified lipopolysaccharide (LPS)-induction of Nrf2 (by 3-5 fold), but had no detectable effect on the initial activation or nuclear translocation of NF kappa B. Because Nrf2 target gene products are known regulators of NF kappa B nuclear activity, our results suggest that Ni(II) may affect cytokine secretion indirectly via modulation of the Nrf2 pathway. (c) 2006 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available